HIGHLIGHTS
- who: Joelle M. Fenger from the Pharmacology, Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA, California, Davis, Davis, CA, United States have published the research work: Pharmacokinetic Exposures Associated With Oral Administration of Sorafenib in Dogs With Spontaneous Tumors, in the Journal: (JOURNAL)
- what: Given the lengthy half-life for this drug class and the potential for drug accumulation to occur in an older population of tumor-bearing dogs, the purpose of the following study was to assess the systemic exposures associated with oral doses of sorafenib at 3 mg . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.